BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4698436)

  • 21. [The persistence after clinical recovery and the suspension of therapy of altered ESR values in a case of meningococcal sepsis and septic shock].
    Zecca G; Del Curto E; Manzoni C
    Minerva Pediatr; 1993 Mar; 45(3):123-6. PubMed ID: 8341226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin for infants and children with meningococcal septicemia. Results of a randomized therapeutic trial.
    Haneberg B; Gutteberg TJ; Moe PJ; Osterud B; Bjorvatn B; Lehmann EH
    NIPH Ann; 1983 Jun; 6(1):43-7. PubMed ID: 6353278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heparin therapy in meningococcal sepsis].
    Masera G; Carnelli V
    Minerva Pediatr; 1969 Feb; 21(8):321. PubMed ID: 5795994
    [No Abstract]   [Full Text] [Related]  

  • 25. [Severe sepsis and septic shock: crossroad between inflammation and coagulation].
    Torrabadella De Reynoso P
    Med Clin (Barc); 2002 Apr; 118(13):517-8. PubMed ID: 11975893
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current clinical and therapeutic aspects of meningococcal infections].
    Mingrino F; Ortali V; Rossi F
    Recenti Prog Med; 1971 Sep; 51(3):250-60. PubMed ID: 5003344
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental meningococcal septicemia. Effect of heparin therapy.
    Gaskins RA; Dalldorf FG
    Arch Pathol Lab Med; 1976 Jun; 100(6):318-24. PubMed ID: 946760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for dopexamine hydrochloride in septic shock.
    Murphy R
    Ir Med J; 1998; 91(5):180. PubMed ID: 9973758
    [No Abstract]   [Full Text] [Related]  

  • 29. [The Meningococcus and its pathology. A symposium sponsored by the French Language Society for Infectious Pathology].
    Modaï J
    Ann Pediatr (Paris); 1985 Jun; 32(6):491-3. PubMed ID: 4026145
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock.
    Michel F; Thomachot L; David M; Nicaise C; Vialet R; Di Marco JN; Lagier P; Martin C
    Am J Emerg Med; 2007 Sep; 25(7):863.e1-2. PubMed ID: 17870513
    [No Abstract]   [Full Text] [Related]  

  • 31. [Haemorrhagic hypovolemic shock and consumptive coagulopathy in a neonate (author's transl)].
    Waltl H; Mitterstieler G
    Klin Padiatr; 1974 Sep; 186(5):455-60. PubMed ID: 4475324
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.
    Derkx B; Wittes J; McCloskey R
    Clin Infect Dis; 1999 Apr; 28(4):770-7. PubMed ID: 10825037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of penicillin therapy of meningococcal infection in children undergoing different regimes of pathogenetic therapy].
    Vereshchagin IA; Kovalenko TI; Kurakina LT
    Antibiotiki; 1983 Oct; 28(10):764-7. PubMed ID: 6651266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical-therapeutical correlations in meningococcal infection: prophylactic heparin therapy (author's transl)].
    Rodríguez-Vigil Lorenzo E; Antuña García MJ; Menéndez M; Poo Argüelles P; Sobrino González A; Suárez Calvo E; Méndez Méndez J; Ramos Polo E; Roza Suárez M
    An Esp Pediatr; 1981 Oct; 15(4):343-8. PubMed ID: 7337300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of blood proteins and glycoproteins in the course of meningococcic disease in childhood (sepsis and meningitis) (cellulose acetate gel radial electrophoresis)].
    Moggi C; Giovannucci ML; Calabri G; Berti S
    Riv Clin Pediatr; 1969; 82():412-6. PubMed ID: 5405496
    [No Abstract]   [Full Text] [Related]  

  • 36. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.
    Fijnvandraat K; Derkx B; Peters M; Bijlmer R; Sturk A; Prins MH; van Deventer SJ; ten Cate JW
    Thromb Haemost; 1995 Jan; 73(1):15-20. PubMed ID: 7740486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of protein C concentrate in pediatric patients with sepsis.
    Silvani P; Camporesi A; Licari E; Wolfler A
    Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia.
    Zenz W; Muntean W; Gallistl S; Zobel G; Grubbauer HM
    Pediatrics; 1995 Jul; 96(1 Pt 1):144-8. PubMed ID: 7596694
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
    Oliveira NS; Silva VR; Castelo JS; Elias-Neto J; Pereira FE; Carvalho WB
    Pediatr Crit Care Med; 2008 Jul; 9(4):414-7. PubMed ID: 18843251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experiences with anticoagulant therapy in children with consumption coagulopathies].
    Lo SS; Frick PG; Straub PW; Hitzig WH
    Bibl Haematol; 1969; 32():298-304. PubMed ID: 5387513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.